{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:35:37Z","timestamp":1772166937870,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"DOI":"10.1215\/15228517-2008-079","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T00:07:14Z","timestamp":1221610034000},"page":"33-40","source":"Crossref","is-referenced-by-count":67,"title":["A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET"],"prefix":"10.1093","volume":"11","author":[{"given":"Murali","family":"Chintagumpala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Hassall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawna","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Kasow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Krasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Dauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Boop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Krance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiao","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Cheuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,2,1]]},"reference":[{"key":"key\n\t\t\t\t20171013074352_REF1","doi-asserted-by":"crossref","unstructured":"Gaffney CC, Sloane JP, Bradley NJ, et al. Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment. J Neurooncol. 1985;3(1): 23-33.","DOI":"10.1007\/BF00165168"},{"key":"key\n\t\t\t\t20171013074352_REF2","doi-asserted-by":"crossref","unstructured":"Bruno LA, Rorke LB, Norris DG. Primitive neuroectodermal tumors of infancy and childhood. In: Humphrey GB, Dehner LP, Grindey GB, et al., eds. Pediatric Oncology. Vol. 1. Boston, MA: Nijhoff; 1985: 265-267.","DOI":"10.1007\/978-94-009-8219-2_15"},{"key":"key\n\t\t\t\t20171013074352_REF3","doi-asserted-by":"crossref","unstructured":"Rorke LB. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumours. J Neuropathol Exp Neurol. 1983;42(1): 1-15.","DOI":"10.1097\/00005072-198301000-00001"},{"key":"key\n\t\t\t\t20171013074352_REF4","doi-asserted-by":"crossref","unstructured":"Cohen BH, Zeltzer PM, Boyett JM, et al. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy. A Children's Cancer Group randomized trial. J Clin Oncol. 1995;13: 1687-1696.","DOI":"10.1200\/JCO.1995.13.7.1687"},{"key":"key\n\t\t\t\t20171013074352_REF5","doi-asserted-by":"crossref","unstructured":"Jakacki RI, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation and\/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children. A report of the Children's Cancer Group. J Clin Oncol. 1995;13: 1377-1383.","DOI":"10.1200\/JCO.1995.13.6.1377"},{"key":"key\n\t\t\t\t20171013074352_REF6","doi-asserted-by":"crossref","unstructured":"Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002;415: 436-442.","DOI":"10.1038\/415436a"},{"key":"key\n\t\t\t\t20171013074352_","doi-asserted-by":"crossref","unstructured":"Russo C, Pellarin M, Tingby O, et al. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer. 1999;86: 331-339.","DOI":"10.1200\/JCO.1999.17.7.2127"},{"key":"key\n\t\t\t\t20171013074352_","doi-asserted-by":"crossref","unstructured":"Nicholson J, Wickramasinghe C, Ross F, Crolla J, Ellison D. Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation. Mol Pathol. 2000;53: 313-319.","DOI":"10.1200\/JCO.1999.17.7.2127"},{"key":"key\n\t\t\t\t20171013074352_REF9","doi-asserted-by":"crossref","unstructured":"Burnett ME, White EC, Sih S, et al. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet. 1997;97: 25-31.","DOI":"10.1016\/S0165-4608(96)00319-6"},{"key":"key\n\t\t\t\t20171013074352_REF10","doi-asserted-by":"crossref","unstructured":"Graham ML, Herndon JE, Casey JR, et al. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol. 1997;15(5): 1814-1823.","DOI":"10.1200\/JCO.1997.15.5.1814"},{"key":"key\n\t\t\t\t20171013074352_REF11","doi-asserted-by":"crossref","unstructured":"Mason WP, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol. 1998;16: 210-221.","DOI":"10.1200\/JCO.1998.16.1.210"},{"key":"key\n\t\t\t\t20171013074352_REF12","doi-asserted-by":"crossref","unstructured":"Broniscer A, Nicolaides TP, Dunkel IJ, et al. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neurectodermal tumors. Pediatr Blood Cancer. 2004;42(3): 261-267.","DOI":"10.1002\/pbc.10369"},{"key":"key\n\t\t\t\t20171013074352_REF13","doi-asserted-by":"crossref","unstructured":"Strother D, Ashley D, Kellie SJ, et al. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol. 2001;19(10): 2696-2704.","DOI":"10.1200\/JCO.2001.19.10.2696"},{"key":"key\n\t\t\t\t20171013074352_REF14","doi-asserted-by":"crossref","unstructured":"Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma\u201396): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7: 813-820.","DOI":"10.1016\/S1470-2045(06)70867-1"},{"key":"key\n\t\t\t\t20171013074352_REF15","doi-asserted-by":"crossref","unstructured":"Stewart CF, Iacono LC, Chintagumpala M, et al. Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor (PNET). J Clin Oncol. 2004;22(16): 3357-3365.","DOI":"10.1200\/JCO.2004.10.103"},{"key":"key\n\t\t\t\t20171013074352_REF16","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Available at http:\/\/ctep.cancer.gov\/reporting\/ctc.html. Accessed August 9, 2006."},{"key":"key\n\t\t\t\t20171013074352_REF17","unstructured":"Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. New York: Psychological Corporation; 1991."},{"key":"key\n\t\t\t\t20171013074352_REF18","unstructured":"Wechsler D. Wechsler Individual Achievement Test. New York: Psychological Corporation; 1992."},{"key":"key\n\t\t\t\t20171013074352_REF19","unstructured":"Sattler JM. Assessment of Children. San Diego, CA; 1992: 1170."},{"key":"key\n\t\t\t\t20171013074352_REF20","unstructured":"Achenbach TM. Manual for the CBCL\/4-18. Burlington, VT: University of Vermont, Department of Psychiatry; 1991."},{"key":"key\n\t\t\t\t20171013074352_REF21","doi-asserted-by":"crossref","unstructured":"Kaplan EJ, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53: 457-482.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"key\n\t\t\t\t20171013074352_REF22","doi-asserted-by":"crossref","unstructured":"Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976;34(6): 585-612.","DOI":"10.1038\/bjc.1976.220"},{"key":"key\n\t\t\t\t20171013074352_REF23","doi-asserted-by":"crossref","unstructured":"Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35(1): 1-39.","DOI":"10.1038\/bjc.1977.1"},{"key":"key\n\t\t\t\t20171013074352_REF24","doi-asserted-by":"crossref","unstructured":"Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York: Springer-Verlag; 2000.","DOI":"10.1007\/978-1-4419-0300-6"},{"key":"key\n\t\t\t\t20171013074352_REF25","doi-asserted-by":"crossref","unstructured":"Albright AL, Wisoff JH, Zeltzer P, et al. Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. A neurosurgical perspective from the Children's Cancer Group. Pediatr Neurosurg. 1995;22(1): 1-7.","DOI":"10.1159\/000121292"},{"key":"key\n\t\t\t\t20171013074352_REF26","doi-asserted-by":"crossref","unstructured":"Reddy AT, Janss AJ, Phillips PC, et al. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer. 2000;88(9): 2189-2193.","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G"},{"key":"key\n\t\t\t\t20171013074352_REF27","doi-asserted-by":"crossref","unstructured":"Pizer BL, Weston CL, Robinson KJ, et al. Analysis of patients with supratentorial primitive neuro-ectodermal tumors entered into the SIOP\/UKCCSG PNET 3 study. Eur J Cancer. 2006;42: 1120-1128.","DOI":"10.1016\/j.ejca.2006.01.039"},{"key":"key\n\t\t\t\t20171013074352_REF28","doi-asserted-by":"crossref","unstructured":"Timmermann B, Kortmann RD, Kuhl J, et al. Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88\/89 and 91. J Clin Oncol. 2002;20(3): 842-849.","DOI":"10.1200\/JCO.2002.20.3.842"},{"key":"key\n\t\t\t\t20171013074352_REF29","doi-asserted-by":"crossref","unstructured":"Massimino M, Gandola L, Spreafico F, et al. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: a prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. Int J Radiat Oncol Biol Phys. 2006;64(4): 1031-1037.","DOI":"10.1016\/j.ijrobp.2005.09.026"},{"key":"key\n\t\t\t\t20171013074352_REF30","doi-asserted-by":"crossref","unstructured":"Kuhl J, Muller HL, Berthold F, et al. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88\/'89. Klin Padiatr. 1998;210(4): 227-233.","DOI":"10.1055\/s-2008-1043883"},{"key":"key\n\t\t\t\t20171013074352_REF31","doi-asserted-by":"crossref","unstructured":"Gururangan S, McLaughlin C, Quinn J, et al. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol. 2003;21: 2187-2191.","DOI":"10.1200\/JCO.2003.10.096"},{"key":"key\n\t\t\t\t20171013074352_REF32","doi-asserted-by":"crossref","unstructured":"Gururangan S, Dunkel I, Goldman S, et al. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol. 1998;16: 2486-2493.","DOI":"10.1200\/JCO.1998.16.7.2486"},{"key":"key\n\t\t\t\t20171013074352_REF33","doi-asserted-by":"crossref","unstructured":"Goldwein JW, Radcliffe J, Johnson J, et al. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol. 1996;34: 889-904.","DOI":"10.1016\/0360-3016(95)02080-2"},{"key":"key\n\t\t\t\t20171013074352_","doi-asserted-by":"crossref","unstructured":"Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol. 1999;17: 2127-2136.","DOI":"10.1200\/JCO.1999.17.7.2127"},{"key":"key\n\t\t\t\t20171013074352_REF35","doi-asserted-by":"crossref","unstructured":"Packer RJ, Gajjar A, Vezina G, et al. Phase III prospective randomized study of craniospinal radiation therapy followed by one of two adjuvant chemotherapy regimens for newly-diagnosed average risk medulloblastoma. J Clin Oncol. 2006;24: 4202-4208.","DOI":"10.1200\/JCO.2006.06.4980"},{"key":"key\n\t\t\t\t20171013074352_REF36","doi-asserted-by":"crossref","unstructured":"Mitby PA, Robison LL, Whitton JA, et al. Utilization of special education services and educational attainment among long-terms survivors of childhood cancer. Cancer. 2003;97: 1115-1126.","DOI":"10.1002\/cncr.11117"},{"key":"key\n\t\t\t\t20171013074352_REF37","doi-asserted-by":"crossref","unstructured":"Butler RW, Mulhern RK. Neurocognitive interventions for children and adolescents surviving cancer. J Pediatr Psychol. 2005;30: 65-78.","DOI":"10.1093\/jpepsy\/jsi017"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/11\/1\/33\/13065117\/07-NO07-00244_Chinta.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T21:40:39Z","timestamp":1557783639000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/11\/1\/33\/1050439\/A-pilot-study-of-riskadapted-radiotherapy-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,2,1]]},"published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1215\/15228517-2008-079","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718450225.793496237","asserted-by":"object"}]},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,2]]},"published":{"date-parts":[[2009,2,1]]}}}